Print

Envisioning Equity in Eye Care Conference CME information

 
Accredited Continuing Education Program Information

The Envisioning Equity in Eye Care Conference, held virtually on November 16 and 17,  is an accredited continuing education activity. There is no additional fee to claim credit. 

Credit may be claimed for participating in the live web sessions and/or viewing the on-demand session recordings. However, participants may not claim credit for participating in the same session live then viewing the recording. 

Statement of need

Many clinician-scientists are not aware of the social and environmental factors (“social determinants”) that result in disparate treatment of eye and vision disorders within the U.S patient population and they may lack the specialized knowledge required to effectively design and execute studies to identify and address these causes of health disparities. In addition, there is a significant lack of underrepresented minorities (URMs) within the eye and vision research and clinical care workforce resulting in less diversity of thought and experience. 

Target audience

The educational design of this activity addresses the needs of researchers, clinician-scientists, ophthalmologists, ophthalmology residents, optometrists, post-doctoral fellows, PhD candidates, and graduate students seeking to learn more about social determinants of health, how to study them and how to design effective interventions within ophthalmic clinical care to address known health disparities. 

Educational objectives

After participating in this CME activity, participants should be able to:

  • Explain the social determinants that effect eye and vision health. 
  • Discuss the epidemiology of health disparities in vision care within the U.S. 
  • Describe how to study healthcare data and genetics to identify health disparities in vision care.
  • Summarize characteristics of effective interventions to improve health equity in vision care within the U.S.  
  • Implement strategies to increase diversity within research or clinical teams. 
  • Explain how to locate and apply for health equity funding opportunities 

Physician Accreditation Statement 

The Association for Research in Vision and Ophthalmology (ARVO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation 

The Association for Research in Vision and Ophthalmology designates this other (blend of internet live and enduring material) activity for a maximum of 6.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Attendees: The American Medical Association (AMA) has determined that physicians not licensed in the U.S who participate in CME activities are eligible for AMA PRA Category 1 Credit™.

Instructions to receive credit and/or certificates

Participants will receive an email with credit claiming instructions prior to the start of the conference. Participants will be instructed to access our online credit claiming site to indicate the extent of their participation in the conference and complete the required participant evaluation form. All requests for credit must be submitted no later than 11:59pm U.S. Eastern Time on December 31, 2022. 

Certificate of Participation

ARVO is accredited to offer AMA PRA Category 1 Credits™ to physicians. All other participants in the accredited activity may receive a Certificate of Participation* that documents the number of accredited hours attended by following the credit claiming instructions. 

*Some accrediting agencies may award equivalent Continuing Education (CE) credit when presented with a Certificate of Participation from an activity that offered AMA PRA Category 1 Credit™. Check with your accrediting agency for information.

Certificate of Attendance

Certificates of attendance are available to all attendees. These certificates state that one has attended the activity but does not offer credit tracking. They will be available via download from the activity web page or by sending an email request to education@arvo.org 

American Board of Ophthalmology (ABO) Diplomates

Successful completion of this accredited continuing education activity, which includes participation in the evaluation component, earns credit toward the Lifelong Learning requirements for the American Board of Ophthalmology’s Continuing Certification program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting credit.

TheEnvisioning Equity in Eye Care Conference qualifies for Lifelong Learning (Part II). Credits will be reported to the ABO via the ACCME no later than January 15, 2023.

Learner data will not be shared with any entity other than the ACCME for the purpose of granting credit. Participants will be able to provide the required information for Continuing Certification credit tracking on the Participant Evaluation Form when claiming credit. By providing the required information, participants will give ARVO permission to share their learner data with the ACCME.

European Union of Medical Specialists (UEMS) CME/CPD requirements 

European physicians can convert AMA PRA Category 1 Credit™ earned from participating in this accredited continuing education activity to meet European Union of Medical Specialists (UEMS) CME/CPD requirements.

The American Medical Association has an agreement of mutual recognition of CME credits with the UEMS, the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at mutualrecognition@uems.eu. 

Contact Us

ARVO
5515 Security Lane, Ste 500
Rockville, Md. 20852, USA
Email: education@arvo.org, p. +1.240.221.2900


Disclaimer

This accredited continuing education activity provides a forum for the open exchange and discussion of research results and scientific advancements in the field of ophthalmology; however, ARVO makes no representation or warranty as to the truth, originality, or accuracy of the information presented at the educational sessions or in materials distributed in connection with them. Nor are the views expressed by the individual speakers necessarily the views of ARVO. ARVO supports ACCME’s policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclaimer off-label use

This activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (Food and Drug Administration). ARVO does not recommend the use of any agent outside of the labeled indications. 

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. 

Disclosure of relevant financial relationships

ARVO requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose all financial relationships with any ineligible company within the last 24 months. All identified relevant financial relationships are thoroughly vetted by ARVO for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations. All relevant financial relationships have been mitigated by ARVO.

ARVO considers presenting authors, not co-authors, to be in control of the educational content. It is ARVO’s policy and traditional scientific publishing practice to acknowledge all people contributing to the research, regardless of CME control of the live presentation of that content. ARVO may collect and publish disclosures from co-authors although they do not have control of the CME content.

Disclosures

Disclosures for all individuals involved in planning and managing this accredited CE activity are listed here with their relevant disclosure information. Disclosure information for presenters will be provided within initial disclosure slides, prior to the start of their respective presentations. 

The following conference organizers reported no relevant financial relationships.
Angela R. Elam, MD; Daisy Y. Shu, PhD

The following individuals on the Professional Development and Education Committee (PDEC) reported no relevant financial relationships. 
Alison Abraham, MS, MHS, PhD; Maria Fernanda Abalem, MD, MSc; Radwan Ajlan, MBBCh, FRCSC, FICO, FASRS; Lin Cheng, MD, PhD; Ngozi Chidi-Egboka, OD, MPH, FNCO, FAAO; Helene Filipe, MD, MMEd; Renu Kowluru, PhD, FARVO; Kristen Nwanyanwu, MD, MBA, MHS; Emily Patterson, PhD, Daisy Y. Shu, PhD; Menglu Yang, MD, PhD

The following activity managers reported no relevant financial relationships.
Regina Borkoski and Cathy Conley

The following clinical content reviewers reported no relevant financial relationships.
Lindsay Scott, PT, DPT, ATC

The following activity planners and managers reported relevant financial relationships. 

Name
Role
Ineligible company (nature of relationship)
  • Adrienne W. Scott, MD, FASRS

Conference organizer

Genentech/Roche: (F,C); Regeneron: (C); DORC: (C); Bausch and Lomb: (C); Alimera Sciences: (C); Novartis: (C)

  • Edmund Tsui, MD

Conference organizer, PDEC

Kowa Company Ltd: (C, F) Cylite Pty Ltd: (F) EyePoint Pharmaceuticals: (C)

  • Azza El-Remessy, PhD,PharmD, BC-ADM

Conference organizer, PDEC

Nour Therapeutics, LLC: (O) – Nour Therapeutics does not meet the definition of an ineligible company, but the relationship is disclosed for full transparency.

  • William Foster, MD, PhD, FRCSC

PDEC

Altasciences: (C, F); Lynthera Corporation: (C); US Patent 9,050,171, Small diameter fragmatome for minimally traumatic retained lens fragments removal: (P)

  • Priya Chaudhary, PhD

PDEC

Alcon Research Institute: (F)

  • Laura Lanford

Activity manager

Johnson & Johnson: (I); Pfizer: (I)

 
Financial relationship disclosure code definitions

C (Consultant/Contractor) Indicates you are a consultant or independent contractor (including contracted research) for an ACCME-defined ineligible company.

E (Employment) Indicates you are an employee of an ACCME-defined ineligible company.

F (Financial Support) Indicates financial support received from an ACCME-defined ineligible company, in the form of research funding (even if the institution receives the research grant and manages the funds), grants, research materials or in-kind services (e.g., sample analysis).

I (Personal Financial Interest) Indicates you are an investor in a company or competing company, including an ACCME-defined ineligible company, other than through a mutual or retirement fund.

N (No Financial Relationship) Indicates there is no financial relationship to disclose.

O (Owner/Co-Owner/Founder/Co-Founder) Indicates you are an owner, co-owner, founder and/or co-founder of an ACCME-defined ineligible company.

P (Patent) Indicates you are an inventor/developer designated on a patent, patent application, copyright, or trade secret, whether the patent, copyright, etc. is presently licensed or otherwise commercialized, or could be in competition with the technology described.

R (Recipient) Indicates you have received gifts, honoraria, travel reimbursement, patent royalties, or any other financial compensation in any amount from an ACCME-defined ineligible company.

S (non-remunerative) Indicates you have position(s) of influence such as officer, board member, trustee, spokesperson, etc.

Conference Registration
Registration for the Envisioning Equity in Eye Care Conference opens Sept. 9
Conference Program
View the daily details of the Envisioning Equity in Eye Care Conference
View now
Keynotes
Meet the Envisioning Equity in Eye Care Conference keynotes
Learn more